History
  • No items yet
midpage
Cacchillo v. Insmed, Inc.
2011 U.S. App. LEXIS 5852
| 2d Cir. | 2011
Read the full case

Background

  • Cacchillo has Type 1 Myotonic Muscular Dystrophy and participated in Insmed's IPLEX clinical trial from Feb to Aug 2008.
  • She alleges IPLEX improved her condition and seeks to resume treatment via FDA compassionate-use authorization.
  • FDA approval for IPLEX is not general; compassionate-use requires Insmed to provide a supporting form to the FDA upon request.
  • Insmed refused to participate, and IPLEX is no longer produced with remaining supply pledged to ALS patients.
  • Cacchillo claims an agreement with Insmed to support her compassionate-use application and seeks a preliminary injunction demanding a supporting document and IPLEX delivery if approved.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Standing for injunctive relief Cacchillo has injury in fact, causation, and redressability via Insmed’s promised document. Injury is not redressable because IPLEX remaining is allocated to ALS patients; standing lacking. Cacchillo has standing to pursue the injunction.
Ripeness of the injunction claim Complaint alleges a current pledge to support her application and an existing sponsor. Ripeness requires concrete sponsor/investigator; no sponsor evidence from Insmed. Claim is ripe for consideration.
Likelihoo d of success on the merits Insmed promised support for compassionate-use application and related documents. No concrete evidence of an enforceable promise; mere site statements and agent’s statements are insufficient. No likelihood of success on the merits.
Redressability and the underlying remedy Court could compel Insmed to provide the document and perform promised actions. Remedies depend on IPLEX availability and ALS allocations; redressability uncertain. Redressability supports standing but does not ensure relief; merits defeat remains.
Impact of substantial delay or maturity of claims Immediate action warranted to enable compassionate-use process. Equitable and practical considerations weigh against injunction given uncertain efficacy and supply. Court affirmed district court on standing/ripeness but upheld denial on merits.

Key Cases Cited

  • Summers v. Earth Island Inst., 555 U.S. 488 (2009) (standing elements for injunctions; redressability considerations)
  • Lujan v. Defenders of Wildlife, 504 U.S. 555 (1992) (standing burden for each claim; progressive evidentiary standard)
  • Lujan v. Nat'l Wildlife Fed'n (Lujan I), 497 U.S. 871 (1990) (summary judgment-like standard for standing at early stages)
  • Sprint Commc'ns Co. v. APCC Servs., Inc., 554 U.S. 269 (2008) (redressability and direct relief considerations)
  • Allen v. Wright, 468 U.S. 737 (1984) (athief concerns about redressability; limitations on remedy)
  • NXIVM Corp. v. Ross Inst., 364 F.3d 471 (2d Cir. 2004) (flexibility to affirm on alternative grounds)
  • Thomas v. Union Carbide Agric. Prods. Co., 473 U.S. 568 (1985) (ripeness; timing and contingent future events)
  • Shain v. Ellison, 356 F.3d 211 (2d Cir. 2004) (standing de novo on appeal; standard of review)
Read the full case

Case Details

Case Name: Cacchillo v. Insmed, Inc.
Court Name: Court of Appeals for the Second Circuit
Date Published: Mar 23, 2011
Citation: 2011 U.S. App. LEXIS 5852
Docket Number: 16-1443
Court Abbreviation: 2d Cir.